DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+0.28%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$35.8B
AUM Growth
+$1.5B
(+4.4%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
3.28%
Top 10 Holdings %
Top 10 Hldgs %
23.91%
Holding
1,455
New
69
Increased
612
Reduced
362
Closed
87
Top Buys
| 1 |
Stellantis
STLA
|
$102M |
| 2 |
Analog Devices
ADI
|
$94.8M |
| 3 |
SPLK
Splunk Inc
SPLK
|
$88.6M |
| 4 |
Amazon
AMZN
|
$86.6M |
| 5 |
UnitedHealth
UNH
|
$82.2M |
Top Sells
| 1 |
Deutsche Bank
DB
|
$338M |
| 2 |
Wells Fargo
WFC
|
$109M |
| 3 |
Qualcomm
QCOM
|
$101M |
| 4 |
Linde
LIN
|
$85.1M |
| 5 |
Baidu
BIDU
|
$62.8M |
Sector Composition
| 1 | Technology | 26.43% |
| 2 | Healthcare | 15.85% |
| 3 | Financials | 11.31% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
1101
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $394K | ﹤0.01% |
5,917
| – | – |
|
1102
Altice USA
ATUS
$1.05B
| $393K | ﹤0.01% |
20,207
-67
| -0.3% | -$1.3K |
|
1103
ImmunityBio
IBRX
$2.27B
| $389K | ﹤0.01% |
41,000
| – | – |
|
|
GOOS
1104
Canada Goose Holdings
GOOS
$1.3B
| $388K | ﹤0.01% |
10,697
| – | – |
|
1105
KE Holdings
BEKE
$22.4B
| $386K | ﹤0.01% |
21,775
-51,610
| -70% | -$915K |
|
1106
Entegris
ENTG
$12.4B
| $386K | ﹤0.01% |
3,000
-2,000
| -40% | -$257K |
|
1107
California Resources
CRC
$4.1B
| $381K | ﹤0.01% |
+9,448
| New | +$381K |
|
|
EGRX
1108
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $379K | ﹤0.01% |
6,900
| – | – |
|
1109
HEICO
HEI
$44.8B
| $375K | ﹤0.01% |
2,804
+61
| +2% | +$8.16K |
|
1110
Theravance Biopharma
TBPH
$703M
| $374K | ﹤0.01% |
51,250
| – | – |
|
1111
Nurix Therapeutics
NRIX
$758M
| $366K | ﹤0.01% |
12,400
| – | – |
|
1112
Axon Enterprise
AXON
$57.2B
| $364K | ﹤0.01% |
2,115
+461
| +28% | +$79.3K |
|
1113
Jackson Financial
JXN
$6.65B
| $364K | ﹤0.01% |
+14,326
| New | +$364K |
|
1114
Imperial Oil
IMO
$44.4B
| $358K | ﹤0.01% |
11,415
+571
| +5% | +$17.9K |
|
1115
Sana Biotechnology
SANA
$752M
| $358K | ﹤0.01% |
16,600
+15,000
| +938% | +$323K |
|
1116
Y-mAbs Therapeutics
YMAB
$390M
| $355K | ﹤0.01% |
12,700
| – | – |
|
1117
AngloGold Ashanti
AU
$30.2B
| $354K | ﹤0.01% |
23,100
-5,000
| -18% | -$76.6K |
|
|
IMGN
1118
DELISTED
Immunogen Inc
IMGN
| $349K | ﹤0.01% |
62,000
| – | – |
|
1119
Schneider National
SNDR
$4.3B
| $342K | ﹤0.01% |
14,909
| – | – |
|
1120
BWX Technologies
BWXT
$15B
| $339K | ﹤0.01% |
6,300
-5,215
| -45% | -$281K |
|
1121
Repare Therapeutics
RPTX
$72.6M
| $332K | ﹤0.01% |
12,900
| – | – |
|
1122
MacroGenics
MGNX
$126M
| $330K | ﹤0.01% |
16,200
| – | – |
|
1123
Sony
SONY
$165B
| $330K | ﹤0.01% |
14,850
+5,500
| +59% | +$122K |
|
1124
Teva Pharmaceuticals
TEVA
$21.7B
| $329K | ﹤0.01% |
33,804
+4,439
| +15% | +$43.2K |
|
1125
Avidity Biosciences
RNA
$6.48B
| $324K | ﹤0.01% |
14,000
| – | – |
|